Abstract
Despite good results of polychemotherapy in head and neck cancer, monochemotherapy retains a valuable role in managing patients with advanced disease. In a palliative setting, lower toxicity and simpler handling of therapy with single agents are outlined by the Authors, who review results of most active drugs in their different schedules.
| Original language | English |
|---|---|
| Pages (from-to) | 303-309 |
| Number of pages | 7 |
| Journal | Chemioterapia |
| Volume | 4 |
| Issue number | 4 |
| Publication status | Published - 1985 |
ASJC Scopus subject areas
- Microbiology (medical)
- Pharmacology (medical)